Navigation Links
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
Date:7/8/2010

NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html

This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics. 

Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.

1: Research Objectives, Method Details, and Segmentation

1.1: Research Objectives and Method Details

Table 1: Research Objectives and Method Details

1.2: Segmentation

2: Executive Summary

2.1: Patient Compliance to Eye Care Medications

2.2: Factors Impacting Eye Care Medication Prescriptions

2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

3: Patient Compliance with Eye Care Medications

3.1: Assessment of Patient Compliance

3.2: Analyst Comments

3.3: Average Number of Medications Taken by Glaucoma Patients

4: Factors Impacting Prescriptions of Eye Care Medications

4.1: Eye Care Medications: Most Important Features

4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications

4.3: Patients' Involvement in Eye Care Medication Selection Process

5: Preferences for Glaucoma Medications

5.1: Prostaglandin Analogues for Glaucoma

5.1.1: Primary Brand Use and Brand Reputation

5.1.2: Brand Loyalty

5.2: Beta Blockers for Glaucoma

5.2.1: Primary Brand Use and Brand Reputation

5.2.2: Brand Loyalty

5.3: Combination Therapies for Glaucoma

5.3.1: Primary Brand Use and Brand Reputation

5.3.2: Brand Loyalty

5.4: Carbonic Anhydrase Inhibitors for Glaucoma

5.4.1: Primary Brand Use and Brand Reputation

5.4.2: Brand Loyalty

5.5: Alpha Adrenergic Agonists for Glaucoma

5.5.1: Primary Brand Use and Brand Reputation

6: Preferences for Other Eye Disease Medications

6.1: Age-Related Macular Degeneration Medications

6.1.1: Primary Brand Use and Brand Reputation

6.1.2: Brand Loyalty

6.1.3: Lucentis Versus Avastin

6.2: Allergic Conjunctivitis Medications

6.2.1: Primary Brand Use and Brand Reputation

6.2.2: Brand Loyalty

6.3: NSAID Medications

6.3.1: Primary Brand Use and Brand Reputation

6.3.2: Brand Loyalty

7: Appendices

7.1: Preferences for Glaucoma Medications

7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.2: Preferences for Other Eye Disease Medications

7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments

To order this report:

Drug and Medication Industry:

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found rising health ... employees of Sun Health Senior Living (SHSL) may not share those same ... and prescription copays for the year, while holding the line on increasing their contributions, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of ... today announced the organization has earned its ISO 13485 certification, indicating the company’s ... with all rules and policies associated with ISO quality standard 13485. , ...
(Date:5/26/2016)... ... ... North Cypress Medical Center hosted its 9th Annual Spring Classic Golf ... of community partners, the event organizers raised $45,000 for the Lone Survivor Foundation ... their families through health, wellness, and therapeutic support. , A special military three-plane ...
(Date:5/26/2016)... ... May 26, 2016 , ... The MIAMI Institute for Age ... speaker Dr. Adonis Maiquez MD, ABAARM. Dr. Adonis , Wellness Physician of the ... a member of the Institute for Functional Medicine. , He also heads up FITTLab, ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... (also knowns as a bunionette) treatment was more than humbled by customer demand over ... one of their SKU's mid sale. Now that Bunion Bootie has completely replenished its ...
Breaking Medicine News(10 mins):